Whether you are a researcher, physician, or creative thinker with training outside biomedicine, we're looking for your thoughts on how best to construct new clinical protocols and execute studies. As an active participant, you'll help us disrupt the current drug development process by making it more efficient, more patient-centric, and ultimately less expensive. Our goal is to achieve a 60-80% reduction in overall trial costs.
Top Challenges for Researchers and Physicians
We are currently working to improve treatment options for the following conditions by improving the designs of clinical trial protocols. Your input on these key challenges will help advance new drug candidates for these and many other conditions.
|Low-Dose Naltrexone ("LDN") in Crohn's||May 2013|
|Lisinopril in Multiple Sclerosis||May 2013|
|PPAR in Parkinson's Disease||May 2013|
Help improve clinical trial protocols and bring new treatments to market
You cannot send more than 3 messages per hour. Please try again later.
I entered biotech eleven years ago after fifteen years in high tech. From molecular modeling and high-content assay tools I moved into drug discovery in protein misfolding diseases. One common theme I experienced was a surplus of good science chasing scarce clinical development capacity.